デフォルト表紙
市場調査レポート
商品コード
1225051

ペット用糖尿病ケアデバイス市場:デバイスタイプ別(グルコースモニタリングデバイス、インスリンデリバリーデバイス)、動物タイプ別(犬、猫)、エンドユーザー別(ホームケア、動物病院、その他):世界の機会分析および産業予測、2021-2031年

Pet Diabetes Care Devices Market By Device Type (Glucose monitoring devices, Insulin delivery devices), By Animal Type (Dogs, Cats), By End Users (Homecare, Veterinary hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: | 発行: Allied Market Research | ページ情報: 英文 | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ペット用糖尿病ケアデバイス市場:デバイスタイプ別(グルコースモニタリングデバイス、インスリンデリバリーデバイス)、動物タイプ別(犬、猫)、エンドユーザー別(ホームケア、動物病院、その他):世界の機会分析および産業予測、2021-2031年
出版日: 2022年12月01日
発行: Allied Market Research
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ペット用糖尿病ケアデバイスの世界市場は、2021年に19億米ドル、2022年から2031年にかけてCAGR6.3%で成長し、2031年には35億米ドルに達すると予測されます。

糖尿病は、体がブドウ糖を正常に利用できなくなったときに起こる症状です。ブドウ糖は体内の細胞の主なエネルギー源です。犬や猫などのペット、また家畜も糖尿病を患っています。ペットの糖尿病は、肥満が大きなリスク要因となりますが、犬の副腎過剰活動、猫の甲状腺機能亢進症、膵炎、心臓病、腎臓病、尿路感染症、皮膚感染症など、糖尿病を引き起こす可能性のある疾患や糖尿病の治療効果に大きな影響を与える可能性のある疾患を発症している場合があります。ペットのこのような状態を治療するために、市場ではグルコースモニタリング機器とインスリンデリバリー機器に二分される機器セグメントが利用可能です。

ペット用糖尿病ケアデバイス市場の成長は、糖尿病の発生率の増加、動物病院での糖尿病監視装置の需要の増加、ペット用糖尿病ケアデバイスの技術的進歩の増加などの要因によって駆動されています。また、人間のいくつかの利点のためのペットの採用の増加、世界中のペットの肥満の例の増加、動物の種類の医療のための有利な政府の支援、ペットの所有者の間で獣医学的医療の重要性についての意識の成長、動物の医療費の上昇と病院&動物医療センターの数の増加も市場の成長に役立っています。例えば、米国ペット用品協会(APPA)のデータによると、2019年、ペットの支出は957億米ドルに達し、2018年より5%増加しました。この支出には、ペットフード、おやつ、市販薬、獣医治療、動物タイプの健康製品、その他のサービス(搭乗、グルーミング、保険、トレーニング、ペットシッター、散歩を含む)などが含まれます。しかし、ペットの糖尿病の適切な管理に関する認知度は低いため、同市場の成長を阻害すると予想されます。逆に、ペット用糖尿病に関する研究開発の活発化は、同市場に大きなチャンスをもたらすと期待されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • ペットの飼育頭数の増加
      • ペットの糖尿病有病率の上昇
      • ペットの肥満の増加
      • 糖尿病治療に関する研究開発の増加
    • 阻害要因
      • 糖尿病治療薬の高価格化
    • 機会
      • 糖尿病治療器具の技術的進歩
  • COVID-19 影響分析

第4章 ペット用糖尿病ケアデバイス市場:デバイスタイプ別

  • 概要
    • 市場規模・予測
  • グルコースモニタリングデバイス
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場シェア分析:国別
  • インスリンデリバリーデバイス
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場シェア分析:国別

第5章 ペット用糖尿病ケアデバイス市場:動物タイプ別

  • 概要
    • 市場規模・予測
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場シェア分析:国別
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場シェア分析:国別

第6章 ペット用糖尿病ケアデバイス市場:エンドユーザー別

  • 概要
    • 市場規模・予測
  • ホームケア
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場シェア分析:国別
  • 動物病院
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場シェア分析:国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場シェア分析:国別

第7章 ペット用糖尿病ケアデバイス市場:地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主要動向と機会
    • 北米市場規模・予測:デバイスタイプ別
    • 北米市場規模・予測:動物タイプ別
    • 北米市場規模・予測:エンドユーザー別
    • 北米市場規模・予測:国別
      • 米国
      • 主な市場動向・成長要因・機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • カナダ
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • メキシコ
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
  • 欧州
    • 主要動向と機会
    • 欧州市場規模・予測:デバイスタイプ別
    • 欧州市場規模・予測:動物タイプ別
    • 欧州市場規模・予測:エンドユーザー別
    • 欧州市場規模・予測:国別
      • ドイツ
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • フランス
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • 英国
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • イタリア
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • スペイン
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • その他欧州
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
  • アジア太平洋地域
    • 主要動向と機会
    • アジア太平洋地域の市場規模・予測:デバイスタイプ別
    • アジア太平洋地域の市場規模・予測:動物タイプ別
    • アジア太平洋地域の市場規模・予測:エンドユーザー別
    • アジア太平洋地域の市場規模・予測:国別
      • 中国
      • 主な市場動向、成長要因、機会
      • 中国市場規模・予測:デバイスタイプ別
      • アジア太平洋地域の市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • 日本
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • インド
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • オーストラリア
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • 韓国
      • 主な市場動向、成長要因、機会
      • 市場規模及び予測:デバイスタイプ別
      • 市場規模及び予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • その他アジア太平洋地域
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
  • ラテンアメリカ・中東・アフリカ
    • 主要動向と機会
    • LAMEAの市場規模・予測:デバイスタイプ別
    • LAMEAの市場規模・予測:動物タイプ別
    • LAMEAの市場規模・予測:エンドユーザー別
    • LAMEA市場の市場規模・予測:国別
      • ブラジル
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • サウジアラビア
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • 南アフリカ
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別
      • LAMEAの残りの地域
      • 主な市場動向、成長要因、機会
      • 市場規模・予測:デバイスタイプ別
      • 市場規模・予測:動物タイプ別
      • 市場規模・予測:エンドユーザー別

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • トップ10プレイヤーの製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • トップ企業のポジショニング、2021年

第9章 企業プロファイル

  • Allison Medical Inc.
  • ALR Technologies Inc.
  • Med Trust LLC
  • Zoetis
  • AccuBioTech Co., Ltd.
  • Merck & Co. Inc.
  • Becton, Dickinson and Company
  • Taidoc Technology Corp.
  • UltiMed, Inc
  • I-SENS. Inc.
図表

LIST OF TABLES

  • TABLE 1. GLOBAL PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. PET DIABETES CARE DEVICES MARKET FOR GLUCOSE MONITORING DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. PET DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. GLOBAL PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. PET DIABETES CARE DEVICES MARKET FOR DOGS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. PET DIABETES CARE DEVICES MARKET FOR CATS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. GLOBAL PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. PET DIABETES CARE DEVICES MARKET FOR HOMECARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. PET DIABETES CARE DEVICES MARKET FOR VETERINARY HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. PET DIABETES CARE DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. PET DIABETES CARE DEVICES MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. NORTH AMERICA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. NORTH AMERICA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA PET DIABETES CARE DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. U.S. PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. U.S. PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. CANADA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. CANADA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. MEXICO PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. MEXICO PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. EUROPE PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. EUROPE PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE PET DIABETES CARE DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. GERMANY PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. GERMANY PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. FRANCE PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. FRANCE PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. FRANCE PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. UK PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. UK PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. UK PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. ITALY PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. ITALY PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ITALY PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. SPAIN PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. SPAIN PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. SPAIN PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. REST OF EUROPE PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. REST OF EUROPE PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. CHINA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. CHINA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. CHINA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. JAPAN PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. JAPAN PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. INDIA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. INDIA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. INDIA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. AUSTRALIA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. AUSTRALIA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. AUSTRALIA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. SOUTH KOREA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. SOUTH KOREA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. SOUTH KOREA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. REST OF ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. LAMEA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. LAMEA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA PET DIABETES CARE DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. BRAZIL PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. BRAZIL PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. SAUDI ARABIA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. SAUDI ARABIA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. SOUTH AFRICA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. SOUTH AFRICA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. SOUTH AFRICA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. REST OF LAMEA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. REST OF LAMEA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. REST OF LAMEA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. ALLISON MEDICAL INC.: KEY EXECUTIVES
  • TABLE 86. ALLISON MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 87. ALLISON MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 88. ALLISON MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 89. ALLISON MEDICAL INC.: NET SALES
  • TABLE 90. ALLISON MEDICAL INC.: KEY STRATERGIES
  • TABLE 91. ALR TECHNOLOGIES INC.: KEY EXECUTIVES
  • TABLE 92. ALR TECHNOLOGIES INC.: COMPANY SNAPSHOT
  • TABLE 93. ALR TECHNOLOGIES INC.: OPERATING SEGMENTS
  • TABLE 94. ALR TECHNOLOGIES INC.: PRODUCT PORTFOLIO
  • TABLE 95. ALR TECHNOLOGIES INC.: NET SALES
  • TABLE 96. ALR TECHNOLOGIES INC.: KEY STRATERGIES
  • TABLE 97. MED TRUST LLC: KEY EXECUTIVES
  • TABLE 98. MED TRUST LLC: COMPANY SNAPSHOT
  • TABLE 99. MED TRUST LLC: OPERATING SEGMENTS
  • TABLE 100. MED TRUST LLC: PRODUCT PORTFOLIO
  • TABLE 101. MED TRUST LLC: NET SALES
  • TABLE 102. MED TRUST LLC: KEY STRATERGIES
  • TABLE 103. ZOETIS: KEY EXECUTIVES
  • TABLE 104. ZOETIS: COMPANY SNAPSHOT
  • TABLE 105. ZOETIS: OPERATING SEGMENTS
  • TABLE 106. ZOETIS: PRODUCT PORTFOLIO
  • TABLE 107. ZOETIS: NET SALES
  • TABLE 108. ZOETIS: KEY STRATERGIES
  • TABLE 109. ACCUBIOTECH CO., LTD.: KEY EXECUTIVES
  • TABLE 110. ACCUBIOTECH CO., LTD.: COMPANY SNAPSHOT
  • TABLE 111. ACCUBIOTECH CO., LTD.: OPERATING SEGMENTS
  • TABLE 112. ACCUBIOTECH CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 113. ACCUBIOTECH CO., LTD.: NET SALES
  • TABLE 114. ACCUBIOTECH CO., LTD.: KEY STRATERGIES
  • TABLE 115. MERCK & CO. INC.: KEY EXECUTIVES
  • TABLE 116. MERCK & CO. INC.: COMPANY SNAPSHOT
  • TABLE 117. MERCK & CO. INC.: OPERATING SEGMENTS
  • TABLE 118. MERCK & CO. INC.: PRODUCT PORTFOLIO
  • TABLE 119. MERCK & CO. INC.: NET SALES
  • TABLE 120. MERCK & CO. INC.: KEY STRATERGIES
  • TABLE 121. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 122. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 123. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 124. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 125. BECTON, DICKINSON AND COMPANY: NET SALES
  • TABLE 126. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
  • TABLE 127. TAIDOC TECHNOLOGY CORP.: KEY EXECUTIVES
  • TABLE 128. TAIDOC TECHNOLOGY CORP.: COMPANY SNAPSHOT
  • TABLE 129. TAIDOC TECHNOLOGY CORP.: OPERATING SEGMENTS
  • TABLE 130. TAIDOC TECHNOLOGY CORP.: PRODUCT PORTFOLIO
  • TABLE 131. TAIDOC TECHNOLOGY CORP.: NET SALES
  • TABLE 132. TAIDOC TECHNOLOGY CORP.: KEY STRATERGIES
  • TABLE 133. ULTIMED, INC: KEY EXECUTIVES
  • TABLE 134. ULTIMED, INC: COMPANY SNAPSHOT
  • TABLE 135. ULTIMED, INC: OPERATING SEGMENTS
  • TABLE 136. ULTIMED, INC: PRODUCT PORTFOLIO
  • TABLE 137. ULTIMED, INC: NET SALES
  • TABLE 138. ULTIMED, INC: KEY STRATERGIES
  • TABLE 139. I-SENS. INC.: KEY EXECUTIVES
  • TABLE 140. I-SENS. INC.: COMPANY SNAPSHOT
  • TABLE 141. I-SENS. INC.: OPERATING SEGMENTS
  • TABLE 142. I-SENS. INC.: PRODUCT PORTFOLIO
  • TABLE 143. I-SENS. INC.: NET SALES
  • TABLE 144. I-SENS. INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1. SEGMENTATION OF PET DIABETES CARE DEVICES MARKET,2021-2031
  • FIGURE 2. PET DIABETES CARE DEVICES MARKET,2021-2031
  • FIGURE 3. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 4. PORTER FIVE-1
  • FIGURE 5. PORTER FIVE-2
  • FIGURE 6. PORTER FIVE-3
  • FIGURE 7. PORTER FIVE-4
  • FIGURE 8. PORTER FIVE-5
  • FIGURE 9. PET DIABETES CARE DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. PET DIABETES CARE DEVICES MARKET,BY DEVICE TYPE,2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF GLUCOSE MONITORING DEVICES PET DIABETES CARE DEVICES MARKET, 2021 AND 2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF INSULIN DELIVERY DEVICES PET DIABETES CARE DEVICES MARKET, 2021 AND 2031(%)
  • FIGURE 13. PET DIABETES CARE DEVICES MARKET,BY ANIMAL TYPE,2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF DOGS PET DIABETES CARE DEVICES MARKET, 2021 AND 2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CATS PET DIABETES CARE DEVICES MARKET, 2021 AND 2031(%)
  • FIGURE 16. PET DIABETES CARE DEVICES MARKET,BY END USERS,2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HOMECARE PET DIABETES CARE DEVICES MARKET, 2021 AND 2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF VETERINARY HOSPITALS PET DIABETES CARE DEVICES MARKET, 2021 AND 2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF OTHERS PET DIABETES CARE DEVICES MARKET, 2021 AND 2031(%)
  • FIGURE 20. PET DIABETES CARE DEVICES MARKET BY REGION,2021
  • FIGURE 21. U.S. PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 22. CANADA PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 23. MEXICO PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 24. GERMANY PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 25. FRANCE PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 26. UK PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 27. ITALY PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 28. SPAIN PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 29. REST OF EUROPE PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 30. CHINA PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 31. JAPAN PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 32. INDIA PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 33. AUSTRALIA PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 34. SOUTH KOREA PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 35. REST OF ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 36. BRAZIL PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 37. SAUDI ARABIA PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 38. SOUTH AFRICA PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 39. REST OF LAMEA PET DIABETES CARE DEVICES MARKET,2021-2031($MILLION)
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44. COMPETITIVE DASHBOARD
  • FIGURE 45. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 46. TOP PLAYER POSITIONING, 2021
  • FIGURE 47. ALLISON MEDICAL INC..: NET SALES ($MILLION)
  • FIGURE 48. ALR TECHNOLOGIES INC..: NET SALES ($MILLION)
  • FIGURE 49. MED TRUST LLC.: NET SALES ($MILLION)
  • FIGURE 50. ZOETIS.: NET SALES ($MILLION)
  • FIGURE 51. ACCUBIOTECH CO., LTD..: NET SALES ($MILLION)
  • FIGURE 52. MERCK & CO. INC..: NET SALES ($MILLION)
  • FIGURE 53. BECTON, DICKINSON AND COMPANY.: NET SALES ($MILLION)
  • FIGURE 54. TAIDOC TECHNOLOGY CORP..: NET SALES ($MILLION)
  • FIGURE 55. ULTIMED, INC.: NET SALES ($MILLION)
  • FIGURE 56. I-SENS. INC..: NET SALES ($MILLION)
目次
Product Code: A12060

The global pet diabetes care devices market was valued at $1.9 billion in 2021, and is projected to reach $3.5 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.  

Diabetes mellitus, or diabetes, is a condition that occurs when the body cannot use glucose normally. Glucose is the main source of energy for the body's cells. Pets such as dogs, cats and also livestock suffer from diabetes too. Obesity is a significant risk factor for development of diabetes in pets, they may also develop other diseases that can result in diabetes or can significantly affect their response to treatment for diabetes, including over activity of the adrenal gland in dogs or hyperthyroidism in cats, pancreatitis, heart disease, kidney disease, urinary tract infections and skin infections. To treat this condition in pets, there are device segments available in the market that are bifurcated into glucose monitoring devices and insulin delivery devices.  

The growth of the pet diabetes care devices market is driven by factors such as increase in incidence of diabetes, increase in demand for diabetes monitoring devices in the veterinary hospitals and increase in the technological advancements of the pet diabetes care devices. Moreover, increase in the adoption of pets for several benefits of the humans, rise in cases of pet obesity across the globe, favorable government support for animal type healthcare, growth in awareness about veterinary healthcare importance among the pet owners, rise in animal healthcare expenditure and increase in the number of hospitals & animal healthcare centers also helps in the growth of the market. For instance, according to the data of American Pet Products Association (APPA), in 2019, the pet expenditure reached $95.7 billion in 2019, which was a 5% increase than 2018. This outlay covers pet food, treats, over-the-counter medicine, vet care, animal type health products and other services (include boarding, grooming, insurance, training, pet sitting and walking). However, the limited awareness surrounding proper management of pet diabetes is expected to hinder the growth of this market. Conversely, increased research initiatives on pet diabetes is expected to create lucrative opportunities for the market. 

The global pet diabetes care devices market is segmented on the basis of device type, animal type, end user and region. On the basis of device type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. On the basis of animal type, the market is classified into dogs and cats. On the basis of end user, the market is classified into homecare, veterinary hospitals and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major companies profiled in the report include AccuBioTech Co., Ltd., Allison Medical Inc., ALR Technologies Inc., Becton, Dickinson and Company, MED Trust, Merck Animal Health, TaiDoc, UltiMed, Inc., Zoetis, i-SENS, Inc. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pet diabetes care devices market analysis from 2021 to 2031 to identify the prevailing pet diabetes care devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pet diabetes care devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pet diabetes care devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Animal Type

  • Dogs
  • Cats

By End Users

  • Homecare
  • Veterinary hospitals
  • Others

By Device Type

  • Glucose monitoring devices
  • Insulin delivery devices

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Allison Medical Inc.
    • ALR Technologies Inc.
    • Med Trust LLC
    • Zoetis
    • AccuBioTech Co., Ltd.
    • Merck & Co. Inc.
    • Becton, Dickinson and Company
    • Taidoc Technology Corp.
    • UltiMed, Inc
    • I-SENS. Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1. Increase in the number of pet adoption.
      • 3.4.1.2. Rise in the prevalence of diabetes in pets.
      • 3.4.1.3. Rise in the pet obesity.
      • 3.4.1.4. Increase in the research and development activity related to the treatment of diabetes.
    • 3.4.2.Restraints
      • 3.4.2.1. High cost of diabetic medications.
    • 3.4.3.Opportunities
      • 3.4.3.1. Technological advancements in the diabetes care devices.
  • 3.5.COVID-19 Impact Analysis on the market

CHAPTER 4: PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2. Glucose monitoring devices
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3. Insulin delivery devices
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2. Dogs
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3. Cats
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: PET DIABETES CARE DEVICES MARKET, BY END USERS

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2. Homecare
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3. Veterinary hospitals
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4. Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: PET DIABETES CARE DEVICES MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Device Type
    • 7.2.3 North America Market size and forecast, by Animal Type
    • 7.2.4 North America Market size and forecast, by End Users
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Device Type
      • 7.2.5.1.3 Market size and forecast, by Animal Type
      • 7.2.5.1.4 Market size and forecast, by End Users
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Device Type
      • 7.2.5.2.3 Market size and forecast, by Animal Type
      • 7.2.5.2.4 Market size and forecast, by End Users
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Device Type
      • 7.2.5.3.3 Market size and forecast, by Animal Type
      • 7.2.5.3.4 Market size and forecast, by End Users
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Device Type
    • 7.3.3 Europe Market size and forecast, by Animal Type
    • 7.3.4 Europe Market size and forecast, by End Users
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Device Type
      • 7.3.5.1.3 Market size and forecast, by Animal Type
      • 7.3.5.1.4 Market size and forecast, by End Users
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Device Type
      • 7.3.5.2.3 Market size and forecast, by Animal Type
      • 7.3.5.2.4 Market size and forecast, by End Users
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Device Type
      • 7.3.5.3.3 Market size and forecast, by Animal Type
      • 7.3.5.3.4 Market size and forecast, by End Users
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Device Type
      • 7.3.5.4.3 Market size and forecast, by Animal Type
      • 7.3.5.4.4 Market size and forecast, by End Users
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Device Type
      • 7.3.5.5.3 Market size and forecast, by Animal Type
      • 7.3.5.5.4 Market size and forecast, by End Users
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Device Type
      • 7.3.5.6.3 Market size and forecast, by Animal Type
      • 7.3.5.6.4 Market size and forecast, by End Users
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Device Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Animal Type
    • 7.4.4 Asia-Pacific Market size and forecast, by End Users
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Device Type
      • 7.4.5.1.3 Market size and forecast, by Animal Type
      • 7.4.5.1.4 Market size and forecast, by End Users
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Device Type
      • 7.4.5.2.3 Market size and forecast, by Animal Type
      • 7.4.5.2.4 Market size and forecast, by End Users
      • 7.4.5.3 India
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Device Type
      • 7.4.5.3.3 Market size and forecast, by Animal Type
      • 7.4.5.3.4 Market size and forecast, by End Users
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Device Type
      • 7.4.5.4.3 Market size and forecast, by Animal Type
      • 7.4.5.4.4 Market size and forecast, by End Users
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Device Type
      • 7.4.5.5.3 Market size and forecast, by Animal Type
      • 7.4.5.5.4 Market size and forecast, by End Users
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Device Type
      • 7.4.5.6.3 Market size and forecast, by Animal Type
      • 7.4.5.6.4 Market size and forecast, by End Users
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Device Type
    • 7.5.3 LAMEA Market size and forecast, by Animal Type
    • 7.5.4 LAMEA Market size and forecast, by End Users
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Device Type
      • 7.5.5.1.3 Market size and forecast, by Animal Type
      • 7.5.5.1.4 Market size and forecast, by End Users
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Device Type
      • 7.5.5.2.3 Market size and forecast, by Animal Type
      • 7.5.5.2.4 Market size and forecast, by End Users
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Device Type
      • 7.5.5.3.3 Market size and forecast, by Animal Type
      • 7.5.5.3.4 Market size and forecast, by End Users
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Device Type
      • 7.5.5.4.3 Market size and forecast, by Animal Type
      • 7.5.5.4.4 Market size and forecast, by End Users

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1 Allison Medical Inc.
    • 9.1.1 Company overview
    • 9.1.2 Key Executives
    • 9.1.3 Company snapshot
    • 9.1.4 Operating business segments
    • 9.1.5 Product portfolio
    • 9.1.6 Business performance
    • 9.1.7 Key strategic moves and developments
  • 9.2 ALR Technologies Inc.
    • 9.2.1 Company overview
    • 9.2.2 Key Executives
    • 9.2.3 Company snapshot
    • 9.2.4 Operating business segments
    • 9.2.5 Product portfolio
    • 9.2.6 Business performance
    • 9.2.7 Key strategic moves and developments
  • 9.3 Med Trust LLC
    • 9.3.1 Company overview
    • 9.3.2 Key Executives
    • 9.3.3 Company snapshot
    • 9.3.4 Operating business segments
    • 9.3.5 Product portfolio
    • 9.3.6 Business performance
    • 9.3.7 Key strategic moves and developments
  • 9.4 Zoetis
    • 9.4.1 Company overview
    • 9.4.2 Key Executives
    • 9.4.3 Company snapshot
    • 9.4.4 Operating business segments
    • 9.4.5 Product portfolio
    • 9.4.6 Business performance
    • 9.4.7 Key strategic moves and developments
  • 9.5 AccuBioTech Co., Ltd.
    • 9.5.1 Company overview
    • 9.5.2 Key Executives
    • 9.5.3 Company snapshot
    • 9.5.4 Operating business segments
    • 9.5.5 Product portfolio
    • 9.5.6 Business performance
    • 9.5.7 Key strategic moves and developments
  • 9.6 Merck & Co. Inc.
    • 9.6.1 Company overview
    • 9.6.2 Key Executives
    • 9.6.3 Company snapshot
    • 9.6.4 Operating business segments
    • 9.6.5 Product portfolio
    • 9.6.6 Business performance
    • 9.6.7 Key strategic moves and developments
  • 9.7 Becton, Dickinson and Company
    • 9.7.1 Company overview
    • 9.7.2 Key Executives
    • 9.7.3 Company snapshot
    • 9.7.4 Operating business segments
    • 9.7.5 Product portfolio
    • 9.7.6 Business performance
    • 9.7.7 Key strategic moves and developments
  • 9.8 Taidoc Technology Corp.
    • 9.8.1 Company overview
    • 9.8.2 Key Executives
    • 9.8.3 Company snapshot
    • 9.8.4 Operating business segments
    • 9.8.5 Product portfolio
    • 9.8.6 Business performance
    • 9.8.7 Key strategic moves and developments
  • 9.9 UltiMed, Inc
    • 9.9.1 Company overview
    • 9.9.2 Key Executives
    • 9.9.3 Company snapshot
    • 9.9.4 Operating business segments
    • 9.9.5 Product portfolio
    • 9.9.6 Business performance
    • 9.9.7 Key strategic moves and developments
  • 9.10 I-SENS. Inc.
    • 9.10.1 Company overview
    • 9.10.2 Key Executives
    • 9.10.3 Company snapshot
    • 9.10.4 Operating business segments
    • 9.10.5 Product portfolio
    • 9.10.6 Business performance
    • 9.10.7 Key strategic moves and developments